While this work primarily focuses on vascular ephrinB2’s modulation of the immune microenvironment, we did not rule out the possibility that loss of ephrinB2 on vessel endothelial cells may also reduce metastasis by preventing cancer cell intravasation. This evidence concerns the gene EFNB2 and cancer.